
ATAI Life Sciences (NASDAQ:ATAI) brought in sales totaling $230.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 194.78%, resulting in a loss of $93.27 million. In Q3, ATAI Life Sciences brought in $266.00 thousand in sales but lost $31.64 million in earnings.